In a nutshell This study evaluated the effectiveness and safety of giving a double dose of tamsulosin (Flomax; 0.8 mg per day) to patients with benign prostatic hyperplasia (BPH) who did not respond to the standard tamsulosin dose (0.4 mg per day) and who could not have prostate surgery. The data showed that a double dose of tamsulosin was an...
Read More
In a nutshell This study reviewed the effectiveness and safety of L-arginine and Pycnogenol® (PAL) in the treatment of male erectile dysfunction (ED). The data showed that the combination of PAL had a significant effect on improving sexual function in patients with mild to moderate ED. Some background Erectile dysfunction (ED) is the persistent...
Read More
In a nutshell This study evaluated the effectiveness of holmium laser enucleation of the median lobe of the prostate (HoLEP) on preserving sexual and urinary function in patients with benign prostatic hyperplasia (BPH). The data showed that HoLEP significantly improved urinary function with preservation of ejaculation (sexual function) in these...
Read More
In a nutshell This study evaluated the effectiveness and safety of salvage radiotherapy (RT) combined with hormone therapy in patients with biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP; prostate removal surgery). This study found that salvage RT combined with hormone therapy was more effective than salvage RT...
Read More
In a nutshell This study reported the long-term effectiveness and safety of enzalutamide (Xtandi) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that enzalutamide in combination with ADT improved the overall survival over the long term with...
Read More
